Covered recipient · General Payments record
DUSTIN MARSHALL CLAYTON
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2025
$2,821.03
- Reported across 137 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $349.86 | 15 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $104.66 | 4 |
| PFIZER INC. | $73.46 | 3 |
| ABIOMED | $38.65 | 1 |
| Kestra Medical Technology Services, Inc. | $25.07 | 1 |
| Lilly USA, LLC | $24.73 | 1 |
| GlaxoSmithKline, LLC. | $18.88 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.03 | 1 |
| E.R. Squibb & Sons, L.L.C. | $17.33 | 1 |
| Amgen Inc. | $14.78 | 1 |
| SCPHARMACEUTICALS INC. | $14.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABIOMED | $38.65 | 12/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174818558 | CMS |
| Amgen Inc. | $14.78 | 11/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229059854 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.03 | 12/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222769967 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.33 | 10/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184759596 | CMS |
| GlaxoSmithKline, LLC. | $18.88 | 12/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190343539 | CMS |
| Kestra Medical Technology Services, Inc. | $25.07 | 10/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248793331 | CMS |
| Lilly USA, LLC | $24.73 | 03/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187129907 | CMS |
| Medtronic, Inc. | $30.57 | 04/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1219777881 | CMS |
| Medtronic, Inc. | $24.33 | 09/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1219777885 | CMS |
| Medtronic, Inc. | $24.18 | 10/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1219777883 | CMS |
| Medtronic, Inc. | $25.58 | 11/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1219777887 | CMS |
| PFIZER INC. | $23.46 | 04/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228939856 | CMS |
| PFIZER INC. | $25.00 | 06/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229339652 | CMS |
| PFIZER INC. | $25.00 | 10/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230452792 | CMS |
| SCPHARMACEUTICALS INC. | $14.27 | 12/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228208052 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.